Suppressions of migration and invasion by cantharidin in TSGH-8301 human bladder carcinoma cells through the inhibitions of matrix metalloproteinase-2/-9 signaling

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Huang, Yi Ping ^a   Ni, Chien Hang ^b   Lu, Chi Cheng ^c   Chiang, Jo Hua ^c   Yang, Jai Sing ^a   Ko, Yang Ching ^d   Lin, Jing Pin ^a   Kuo, Jehn Hwa ^e,f   Chang, Shu Jen ^a   Chung, Jing Gung ^a,g  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b E DA HOSPITAL   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d ST MARTIN DE PORRES HOSPITAL   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f JEN AI HOSPITAL   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; GELATIN; GELATINASE A; GELATINASE B; SYNAPTOPHYSIN;

ARTICLE; BEETLE; BLADDER CARCINOMA; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

EID: 84874549043     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/190281     Document Type: Article

References (42)

1. Hussain S. A., James N. D., The systemic treatment of advanced and metastatic bladder cancer. Lancet Oncology 2003 4 8 489 497 2-s2.0-0042477610 10.1016/S1470-2045(03)01168-9 (Pubitemid 37009957)
2. Hernandez B. Y., Green M. D., Cassel K. D., Pobutsky A. M., Vu V., Wilkens L. R., Preview of Hawaii cancer facts and figures 2010. Hawaii Medical Journal 2010 69 9 223 224 2-s2.0-77958190258
3. Messing E. M., Young T. B., Hunt V. B., Gilchrist K. W., Newton M. A., Bram L. L., Hisgen W. J., Barry Greenberg E., Kuglitsch M. E., Wegenke J. D., Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995 45 3 387 397 2-s2.0-0028802758 10.1016/S0090-4295(99)80006-5
4. Whitmore W. F. Jr., Management of invasive bladder neoplasms. Seminars in Urology 1983 1 1 34 41 2-s2.0-0020703531
5. Zhang X., Shi X., Li J., A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer. Journal of Urology 2012 187 3 1071 1079 10.1016/j.juro.2011.10.126
6. Raghavan D., Shipley W. U., Garnick M. B., Russell P. J., Richie J. P., Biology and management of bladder cancer. New England Journal of Medicine 1990 322 16 1129 1138 2-s2.0-0025321388 (Pubitemid 20149531)
7. Stein J. P., Lieskovsky G., Cote R., Groshen S., Feng A. C., Boyd S., Skinner E., Bochner B., Thangathurai D., Mikhail M., Raghavan D., Skinner D. G., Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. Journal of Clinical Oncology 2001 19 3 666 675 2-s2.0-0035254218 (Pubitemid 32120143)
8. Liu P. L., Tsai J. R., Charles A. L., Hwang J. J., Chou S. H., Ping Y. H., Lin F. Y., Chen Y. L., Hung C. Y., Chen W. C., Chen Y. H., Chong I. W., Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor- B pathway and subsequently downregulating expression of matrix metalloproteinases. Molecular Nutrition and Food Research 2010 54 supplement 2 S196 S204 2-s2.0-77957590701 10.1002/mnfr.200900550
9. Christofori G., New signals from the invasive front. Nature 2006 441 7092 444 450 2-s2.0-33745297408 10.1038/nature04872 (Pubitemid 44050139)
10. Folgueras A. R., Pendas A. M., Sanchez L. M., Lopez-Otin C., Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. The International Journal of Developmental Biology 2004 48 5-6 411 424 10.1387/ijdb.041811af (Pubitemid 39360392)
11. Kessenbrock K., Plaks V., Werb Z., Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010 141 1 52 67 2-s2.0-77950931419 10.1016/j.cell.2010.03.015
12. Coussens L. M., Fingleton B., Matrisian L. M., Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002 295 5564 2387 2392 2-s2.0-0037192458 10.1126/science.1067100 (Pubitemid 34270240)
13. Li W., Xie L., Chen Z., Zhu Y., Sun Y., Miao Y., Xu Z., Han X., Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis. Cancer Science 2010 101 5 1226 1233 2-s2.0-77953204596 10.1111/j.1349-7006.2010.01523.x
14. McCluskey A., Ackland S. P., Bowyer M. C., Baldwin M. L., Garner J., Walkom C. C., Sakoff J. A., Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines. Bioorganic Chemistry 2003 31 1 68 79 2-s2.0-0037305812 10.1016/S0045-2068(02)00524-2 (Pubitemid 36411927)
15. Honkanen R. E., Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Letters 1993 330 3 283 286 2-s2.0-0027217027 10.1016/0014-5793(93)80889-3 (Pubitemid 23276340)
16. Clarke P. R., Hoffmann I., Draetta G., Karsenti E., Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts. Molecular Biology of the Cell 1993 4 4 397 411 2-s2.0-0027538301 (Pubitemid 23122127)
17. Ishida Y., Furukawa Y., Decaprio J. A., Saito M., Griffin J. D., Treatment of myeloid leukemia cells with the phosphatase inhibitor okadaic acid induces cell cycle arrest at either G1/S or G2/M depending on dose. Journal of Cellular Physiology 1992 150 3 484 492 2-s2.0-0026609930
18. Chen Y. N., Chen J. C., Yin S. C., Wang G. S., Tsauer W., Hsu S. F., Hsu S. L., Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. International Journal of Cancer 2002 100 2 158 165 2-s2.0-0037054929 10.1002/ijc.10479 (Pubitemid 34666189)
19. Kang H. S., Lee B. S., Yang Y., Park C. W., Ha H. J., Pyun K. H., Choi I., Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells. Cellular Immunology 1996 168 2 174 183 2-s2.0-0029947212 10.1006/cimm.1996.0064 (Pubitemid 26111180)
20. Kok S. H., Cheng S. J., Hong C. Y., Lee J. J., Lin S. K., Kuo Y. S., Chiang C. P., Kuo M. Y. P., Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Letters 2005 217 1 43 52 2-s2.0-10444235120 10.1016/j.canlet.2004. 07.045 (Pubitemid 39642865)
21. Dorn D. C., Kou C. A., Png K. J., Moore M. A. S., The effect of cantharidins on leukemic stem cells. International Journal of Cancer 2009 124 9 2186 2199 2-s2.0-63449135103 10.1002/ijc.24157
22. Yi S., Wass J., Vincent P., Iland H., Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro. Leukemia Research 1991 15 10 883 886 2-s2.0-0026095943 10.1016/0145-2126(91)90163-N
23. Ray R. M., Bhattacharya S., Johnson L. R., Protein phosphatase 2A regulates apoptosis in intestinal epithelial cells. Journal of Biological Chemistry 2005 280 35 31091 31100 2-s2.0-24744454380 10.1074/jbc.M503041200 (Pubitemid 41291844)
24. Kuo J. H., Chu Y. L., Yang J. S., Lin J. P., Lai K. C., Kuo H. M., Hsia T. C., Chung J. G., Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria-dependent signal pathways. International Journal of Oncology 2010 37 5 1243 1250 2-s2.0-77957873171 10.3892/ijo-00000775
25. Huang W. W., Ko S. W., Tsai H. Y., Chung J. G., Chiang J. H., Chen K. T., Chen Y. C., Chen H. Y., Chen Y. F., Yang J. S., Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. International Journal of Oncology 2011 38 4 1067 1073 2-s2.0-79952327221 10.3892/ijo.2011.922
26. Chen N. G., Lu C. C., Lin Y. H., Shen W. C., Lai C. H., Ho Y. J., Chung J. G., Lin T. H., Lin Y. C., Yang J. S., Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways. Oncology Reports 2011 26 4 939 947 2-s2.0-79960798062 10.3892/or.2011.1377
27. Lu C. C., Yang J. S., Chiang J. H., Novel quinazolinone MJ-29 triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic mice. PLoS ONE 2012 7 5, article e36831
28. Liu K. C., Huang A. C., Wu P. P., Lin H. Y., Chueh F. S., Yang J. S., Lu C. C., Chiang J. H., Meng M., Chung J. G., Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. Oncology Reports 2011 26 1 177 184 2-s2.0-79955796236 10.3892/or.2011.1264
29. Ma C. Y., Ji W. T., Chueh F. S., Butein inhibits the migration and invasion of SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK, JNK, p38, and uPA signaling multiple pathways. Journal of Agricultural and Food Chemistry 2011 59 16 9032 9038 10.1021/jf202027n
30. Liao C. L., Lai K. C., Huang A. C., Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways. Food and Chemical Toxicology 2012 50 5 1734 1740 10.1016/j.fct.2012.02.033
31. Chen Y. Y., Chiang S. Y., Lin J. G., Ma Y. S., Liao C. L., Weng S. W., Lai T. Y., Chung J. G., Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. International Journal of Oncology 2010 36 5 1113 1120 2-s2.0-77950455995 10.3892/ijo-00000593
32. Ho Y. T., Yang J. S., Li T. C., Lin J. J., Lin J. G., Lai K. C., Ma C. Y., Wood W. G., Chung J. G., Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF- B, u-PA and MMP-2 and -9. Cancer Letters 2009 279 2 155 162 2-s2.0-67349103384 10.1016/j.canlet.2009.01.033
33. Chiang J. H., Yang J. S., Ma C. Y., Yang M. D., Huang H. Y., Hsia T. C., Kuo H. M., Wu P. P., Lee T. H., Chung J. G., Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways. Chemical Research in Toxicology 2011 24 1 20 29 2-s2.0-78651497947 10.1021/tx100248s
34. Lu C. C., Yang J. S., Huang A. C., Hsia T. C., Chou S. T., Kuo C. L., Lu H. F., Lee T. H., Wood W. G., Chung J. G., Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Molecular Nutrition and Food Research 2010 54 7 967 976 2-s2.0-77954648680 10.1002/mnfr.200900265
35. Lu C. C., Yang J. S., Chiang J. H., Inhibition of invasion and migration by newly synthesized quinazolinone MJ-29 in human oral cancer CAL 27 cells through suppression of MMP-2/9 expression and combined down-regulation of MAPK and AKT signaling. Anticancer Research 2012 32 7 2895 2903
36. Lai K. C., Huang A. N. C., Hsu S. C., Kuo C. L., Yang J. S., Wu S. H., Chung J. G., Benzyl Lsothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. Journal of Agricultural and Food Chemistry 2010 58 5 2935 2942 2-s2.0-77949351356 10.1021/jf9036694
37. Yang S. F., Chen M. K., Hsieh Y. S., Yang J. S., Zavras A. I., Hsieh Y. H., Su S. C., Kao T. Y., Chen P. N., Chu S. C., Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases. Food and Chemical Toxicology 2010 48 4 1052 1058 2-s2.0-77549086838 10.1016/j.fct.2010.01.019
38. Gialeli C., Theocharis A. D., Karamanos N. K., Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. The FEBS Journal 2011 278 1 16 27 2-s2.0-78650424066 10.1111/j.1742-4658.2010. 07919.x
39. Chen P. N., Hsieh Y. S., Chiou H. L., Chu S. C., Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chemico-Biological Interactions 2005 156 2-3 141 150 2-s2.0-26044455880 10.1016/j.cbi.2005.08.005 (Pubitemid 41406237)
40. Hsiao Y. C., Kuo W. H., Chen P. N., Chang H. R., Lin T. H., Yang W. E., Hsieh Y. S., Chu S. C., Flavanone and 2 ′ -OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway. Chemico-Biological Interactions 2007 167 3 193 206 2-s2.0-34047149367 10.1016/j.cbi.2007.02.012 (Pubitemid 46529404)
41. Rao J. S., Molecular mechanisms of glioma invasiveness: the role of proteases. Nature Reviews Cancer 2003 3 7 489 501 2-s2.0-0041737535 (Pubitemid 37328837)
42. Westermarck J., Kähäri V. M., Regulation of matrix metalloproteinase expression in tumor invasion. The FASEB Journal 1999 13 8 781 792 2-s2.0-0345643514 (Pubitemid 29220691)